<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>FBR Cross-Indication Bridge Plan</title>
    <style>
        @page {
            size: A4;
            margin: 0;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: white;
            padding: 40px 50px;
            line-height: 1.4;
            font-size: 10.5pt;
        }
        
        .header {
            text-align: center;
            margin-bottom: 20px;
            padding-bottom: 12px;
            border-bottom: 3px solid #2c5282;
        }
        
        h1 {
            font-size: 18pt;
            color: #1a365d;
            margin-bottom: 4px;
            font-weight: 700;
        }
        
        .subtitle {
            font-size: 11pt;
            color: #4a5568;
            font-style: italic;
            margin-top: 4px;
        }
        
        h2 {
            font-size: 12pt;
            color: #2c5282;
            margin-top: 14px;
            margin-bottom: 8px;
            padding-bottom: 3px;
            border-bottom: 1.5px solid #90cdf4;
            font-weight: 600;
        }
        
        h3 {
            font-size: 10.5pt;
            color: #2d3748;
            margin-top: 10px;
            margin-bottom: 5px;
            font-weight: 600;
        }
        
        p, li {
            margin-bottom: 5px;
            color: #2d3748;
        }
        
        ul {
            margin-left: 20px;
            margin-bottom: 8px;
        }
        
        li {
            margin-bottom: 3px;
        }
        
        .section {
            margin-bottom: 14px;
        }
        
        .highlight-box {
            background: #ebf8ff;
            border-left: 4px solid #3182ce;
            padding: 10px 12px;
            margin: 10px 0;
        }
        
        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
            margin: 8px 0;
        }
        
        .column {
            padding: 8px;
        }
        
        .protocol-step {
            margin-bottom: 6px;
            padding-left: 8px;
        }
        
        .step-number {
            font-weight: 700;
            color: #2c5282;
        }
        
        .regulatory {
            background: #f7fafc;
            border: 2px solid #cbd5e0;
            border-radius: 6px;
            padding: 12px;
            margin-top: 12px;
        }
        
        strong {
            color: #1a365d;
        }
        
        .footer {
            margin-top: 16px;
            padding-top: 8px;
            border-top: 1px solid #e2e8f0;
            text-align: center;
            font-size: 9pt;
            color: #718096;
        }
        
        @media print {
            body {
                padding: 30px 40px;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>FBR Cross-Indication Bridge Plan</h1>
        <div class="subtitle">AKI ‚Üí MI (or Reverse): One Platform, Two Indications</div>
    </div>

    <div class="highlight-box">
        <strong>Core Concept:</strong> Use the same oral trigger (Module 1) and EV platform (Module 2) across models‚Äîonly swap tissue-specific ligands and cargo. <strong>Mobilize once, target twice.</strong>
    </div>

    <div class="section">
        <h2>Shared Backbone</h2>
        <ul>
            <li><strong>Module 1:</strong> Enteric G-CSF mimetic ‚Äî triggers systemic progenitor surge (CD34‚Å∫/c-kit‚Å∫)</li>
            <li><strong>Module 2:</strong> Core EV scaffold ‚Äî &lt;120 nm, PEGylated, miR-21 + VEGF loaded</li>
            <li><strong>Swap Ligands:</strong>
                <ul>
                    <li><strong>AKI:</strong> Anti-megalin (tubular targeting)</li>
                    <li><strong>MI:</strong> Anti-CD44 (endothelial, cardiomyocyte targeting)</li>
                </ul>
            </li>
        </ul>
    </div>

    <div class="section">
        <h2>Bridge Protocol (High-Level)</h2>
        
        <div class="protocol-step">
            <span class="step-number">1. Day ‚Äì1:</span> Oral dose ‚Äî mobilize BM pool
        </div>
        
        <div class="protocol-step">
            <span class="step-number">2. Injury Window:</span> Induce AKI (IRI) or MI (LAD) ‚Äî clamp time 30‚Äì45 min
        </div>
        
        <div class="protocol-step">
            <span class="step-number">3. Post-reperfusion:</span> IV EV bolus ‚Äî 2h after reperfusion (ROS/apoptosis peak)
        </div>
        
        <div class="protocol-step">
            <span class="step-number">4. Readouts (Day 3‚Äì7):</span>
            <div class="two-column">
                <div class="column">
                    <strong>AKI:</strong>
                    <ul>
                        <li>Cr/NGAL drop</li>
                        <li>Tubular proliferation (Ki67)</li>
                    </ul>
                </div>
                <div class="column">
                    <strong>MI:</strong>
                    <ul>
                        <li>EF gain</li>
                        <li>Scar reduction (MRI)</li>
                        <li>CD31‚Å∫ density</li>
                    </ul>
                </div>
            </div>
        </div>
        
        <div class="protocol-step">
            <span class="step-number">5. Crossover Test (Pilot only):</span> Same animal ‚Äî unilateral AKI + induced arrhythmia ‚Üí Does EV home to both kidney and heart?
        </div>
    </div>

    <div class="regulatory">
        <h2 style="margin-top: 0; border: none; padding-bottom: 0;">Regulatory Angle</h2>
        <p style="margin-top: 8px;"><strong>One CMC dossier. Two indications.</strong></p>
        <p><strong>One potency assay:</strong> CD34‚Å∫ migration + tissue uptake fluorescence</p>
        <p style="margin-top: 8px; font-weight: 600; color: #2c5282;">Saves ~$800K and 6 months development time</p>
    </div>

    <div class="footer">
        FBR Cross-Indication Bridge Plan | Confidential | Version 1.0
    </div>

    <script>
        // Auto-print functionality
        window.onload = function() {
            const button = document.createElement('button');
            button.textContent = 'üìÑ Download as PDF';
            button.style.cssText = `
                position: fixed;
                top: 20px;
                right: 20px;
                padding: 12px 24px;
                background: #2c5282;
                color: white;
                border: none;
                border-radius: 6px;
                font-size: 14px;
                font-weight: 600;
                cursor: pointer;
                box-shadow: 0 4px 6px rgba(0,0,0,0.1);
                z-index: 1000;
            `;
            button.onmouseover = () => button.style.background = '#1a365d';
            button.onmouseout = () => button.style.background = '#2c5282';
            button.onclick = () => window.print();
            document.body.appendChild(button);
        };
    </script>
</body>
</html>
